Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

5.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

586
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
586
Teratogenicity01:07

Teratogenicity

4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Proliferative Phase01:20

Proliferative Phase

1.9K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.9K
Secretory Phase01:19

Secretory Phase

2.8K
The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal first trimester SIMPLE nutritional score and intrauterine fetal growth trajectory: a prospective multicentre Italian study (SIMPLE study).

The British journal of nutrition·2026
Same author

Placenta accreta spectrum: clinical and radiological follow-up after conservative management and maternal complications.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Reply: Missing the target.

Human reproduction (Oxford, England)·2024
Same author

Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023.

Facts, views & vision in ObGyn·2024
Same author

Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.

Journal of endocrinological investigation·2023
Same author

Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms.

Scientific reports·2021
Same journal

Immediate volume reduction following transvaginal ultrasound-guided thermal ablation (interstitial myolysis) of a symptomatic uterine fibroid.

Facts, views & vision in ObGyn·2026
Same journal

Retained intrauterine devices and abdominal actinomycosis, diagnostic challenges from a case series.

Facts, views & vision in ObGyn·2026
Same journal

"Pocket sign" on hysterosalpingography: an adjunctive imaging finding suggestive of caesarean isthmocele.

Facts, views & vision in ObGyn·2026
Same journal

Music and oral premedication for pain management during outpatient hysteroscopy: results from a randomised controlled trial.

Facts, views & vision in ObGyn·2026
Same journal

Conventional laparoscopic segmental bowel resection with mini-laparotomy specimen extraction compared with Natural Orifice Specimen Extraction (NOSE) procedures in patients with colorectal endometriosis.

Facts, views & vision in ObGyn·2026
Same journal

Postoperative and long-term outcomes of nerve-sparing segmental rectal resection and complete nodular resection of rectal endometriosis.

Facts, views & vision in ObGyn·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.3K

Postterm pregnancy.

M Galal1, I Symonds2, H Murray3

  • 1Consultant/Conjoint Senior Lecturer in Obstetrics & Gynaecology, John Hunter Hospital, University of Newcastle, New South Wales, Australia.

Facts, Views & Vision in Obgyn
|April 23, 2014
PubMed
Summary
This summary is machine-generated.

Inducing labor at 41 weeks for postterm pregnancies can improve outcomes. This approach may reduce fetal and maternal complications without increasing cesarean section rates.

Keywords:
Body mass indexinduction of labourperinatal complicationspostterm pregnancyultrasound

More Related Videos

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.7K
A Preterm Rat Model for Pain Studies
01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

1000

Related Experiment Videos

Last Updated: May 1, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

1.3K
Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
03:01

Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity

Published on: August 2, 2024

2.7K
A Preterm Rat Model for Pain Studies
01:37

A Preterm Rat Model for Pain Studies

Published on: February 9, 2024

1000

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine

Background:

  • Postterm pregnancy, extending beyond 42 weeks, carries underestimated fetal, neonatal, and maternal risks.
  • Complication incidence, including stillbirth, rises significantly before 42 weeks, starting from 39 weeks gestation.
  • Current management of postterm pregnancy poses challenges regarding induction timing and method.

Purpose of the Study:

  • To evaluate the benefits of labor induction at 41 weeks gestation for postterm pregnancies.
  • To assess the impact of induction on perinatal and maternal complications.
  • To determine if induction at 41 weeks affects cesarean section rates.

Main Methods:

  • Review of existing evidence on postterm pregnancy management and labor induction.
  • Analysis of studies comparing outcomes of induction before versus after 42 weeks.
  • Examination of data on complication rates and cesarean section rates in relation to induction timing.

Main Results:

  • Evidence suggests labor induction between 40-42 weeks reduces perinatal complications.
  • Induction of labor at term, particularly between 40 and 42 weeks, is linked to decreased perinatal issues.
  • Studies indicate that induction prior to 42 weeks does not necessarily increase cesarean section rates.

Conclusions:

  • Induction of labor at 41 weeks for postterm pregnancies appears beneficial.
  • A policy of induction at 41 weeks could improve perinatal outcomes.
  • This strategy may lead to a reduction in maternal complications associated with postterm pregnancy.